← Leaderboards
Luca Busino
University Of Pennsylvania
$6,731,473
Attributed
$9,723,787
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,723,787 · 6
By mechanism
R01$8,931,343 · 4
R00$702,444 · 1
K99$90,000 · 1
Top collaborators
- Iannis Aifantis4 shared
- Donita C Brady4 shared
- George Burslem4 shared
- Terence P Gade4 shared
- Eric S. Witze4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- J. Kevin Kevin Foskett$22,784,994
- Dejian Ren$10,845,009
- Don-On Daniel Mak$4,975,182
- Diego Contreras$9,343,544
- Chi Li$3,939,189
Others in their field
Top investigators on “Protein Degradation”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Jeffery W Kelly · Scripps Research Institute$26,820,426
- Alexander J Varshavsky · California Institute Of Technology$26,534,363
- Rama K Mallampalli · Ohio State University$24,781,659
- Larry Arthur$22,516,306
- Robert T Sauer · Massachusetts Institute Of Technology$22,030,267
Research focus
Protein DegradationMalignant NeoplasmsSignal PathwayMolecularLinkRegulationPathway InteractionsProteasome InhibitorUbiquitin-Protein LigaseUbiquitinCellsBortezomibMutationComplexMulticatalytic Endopeptidase ComplexPersonalized TherapeuticResponseIn VivoSuccessProteomicsCell ProliferationGenesPathogenesisCell Line
Grant awards (23)
Unlocking the Chemical Space of Cancer-Associated Perturbations$863,577
R01 · FY2025 · CA
Assessment of DCAF15 role in Acute Myeloid Leukemia$483,760
R01 · FY2025 · CA · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$406,250
R01 · FY2025 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$615,348
R01 · FY2024 · HL · contact PI
Unlocking the Chemical Space of Cancer-Associated Perturbations$431,789
R01 · FY2024 · CA
Role of KLHL6 inactivation in mature B-cell malignancies$385,938
R01 · FY2024 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$627,906
R01 · FY2023 · HL · contact PI
Unlocking the Chemical Space of Cancer-Associated Perturbations$431,789
R01 · FY2023 · CA
Role of KLHL6 inactivation in mature B-cell malignancies$398,125
R01 · FY2023 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$633,818
R01 · FY2022 · HL · contact PI
Unlocking the Chemical Space of Cancer-Associated Perturbations$431,789
R01 · FY2022 · CA
Role of KLHL6 inactivation in mature B-cell malignancies$406,250
R01 · FY2022 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$653,245
R01 · FY2021 · HL · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$368,288
R01 · FY2020 · CA · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$426,424
R01 · FY2019 · CA · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$368,288
R01 · FY2018 · CA · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$262,183
R01 · FY2018 · CA · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$368,288
R01 · FY2017 · CA · contact PI
Role of KLHL6 inactivation in mature B-cell malignancies$368,288
R01 · FY2016 · CA · contact PI
Specificity of the Ubiquitin System in Lymphoid Malignancies$235,667
R00 · FY2016 · CA · contact PI
Specificity of the Ubiquitin System in Lymphoid Malignancies$242,678
R00 · FY2015 · CA · contact PI
Specificity of the Ubiquitin System in Lymphoid Malignancies$224,099
R00 · FY2014 · CA · contact PI
Specificity of the Ubiquitin System in Lymphoid Malignancies$90,000
K99 · FY2013 · CA · contact PI